The cybersecurity commercialisation firm hopes to raise $2.9m through an Aim placement and will use the funding for product development, working capital, sales and marketing.

The funding from crowdfunding platform SyndicateRoom is part of a wider series B round for Manchester gel therapy developer Gelmetix and adds to approximately $1.3m raised in 2014 and 2015.

The sleep disorder treatment developer has raised an additional $17.1m in a round led by medical device maker Cochlear.

The music festival ticket marketplace plans to expand into North America and Asia having secured $10.5m from investors including Channel 4's Commercial Growth Fund and InMotion Ventures.

Swisscom Ventures co-led the indoor drone developer's series B round, which also featured Dow Chemical and existing backers including MKS.

The corporate has resurrected the Schneider Electric Ventures unit it folded into Aster in 2010 and will invest up to $565m through the vehicle.

Boehringer Ingelheim and Helsinn helped University of Geneva vaccine spinout Amal reach the second close of a series B round that now totals $32.7m.

SetSquared member Duel has added UBEF II to investors including London Co-Investment Fund as it looks to drive adoption of its advocacy marketing platform.

Existing investors SoftBank Vision Fund and Dexxon both returned for a $200m round that will help drug developer Roivant Sciences expand its range of subsidiaries.

SNCF has invested in BlaBlaCar, the buyer of its bus transport subsidiary, Ouibus, in a round that took the carpooling platform's total funding to $450m.